Ondansetron: A Novel Treatment to Reduce the Severity of Neonatal Opioid Withdrawal Syndrome?

Intended Audience: All neonatal nurses

ANCC NCPD Contact Hour(s): 1.0

NCC Category Codes: NIC3, NNP4

Learning Outcome: Upon completion of this activity the learner will report an increased knowledge regarding the use of Ondansetron to treat neonatal abstinence syndrome.

Release Date: November/December 2025
Expiration Date: December 31, 2028 

Disclosures: No persons with the potential to control the content of this activity have relevant financial relationships with any commercial company that may be related to the subjects discussed within this article. Neither ANN nor the American Nurses Credentialing Center (ANCC) endorses any commercial products discussed/displayed in conjunction with this educational activity.

Click Here for Accreditation Information, Requirements for earning CNE contact hours, and Disclaimer

Keywords: pharmacology, neurology, research, evidence-based practice, NICU Care

Author: Susan Givens Bell DNP, MABMH, NNP-BC, RNC-NIC

Key:

Complete
Failed
Available
Locked
Journal Article
Open to download resource.
Open to download resource.
You must register to access.
Exam: Ondansetron: A Novel Treatment to Reduce the Severity of Neonatal Opioid Withdrawal Syndrome?
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
You must register to access.
NCPD Evaluation Home Study
5 Questions
5 Questions
You must register to access.
Certificate
1.00 ANCC NCPD Contact Hours credit  |  Certificate available
1.00 ANCC NCPD Contact Hours credit  |  Certificate available
You must register to access.